Item Type | Name |
Concept
|
Leukemia, Myeloid, Acute
|
Academic Article
|
TTID: A novel gene at 5q31 encoding a protein with titin-like features.
|
Academic Article
|
Expression profiling of CD34+ hematopoietic stem/ progenitor cells reveals distinct subtypes of therapy-related acute myeloid leukemia.
|
Academic Article
|
A phase I biological study of MG98, an oligodeoxynucleotide antisense to DNA methyltransferase 1, in patients with high-risk myelodysplasia and acute myeloid leukemia.
|
Academic Article
|
Outcomes of patients with AML and MDS who relapse or progress after reduced intensity allogeneic hematopoietic cell transplantation.
|
Academic Article
|
Therapy-related myeloid leukemia.
|
Academic Article
|
Results from a randomized trial of salvage chemotherapy followed by lestaurtinib for patients with FLT3 mutant AML in first relapse.
|
Academic Article
|
Leukemic IDH1 and IDH2 mutations result in a hypermethylation phenotype, disrupt TET2 function, and impair hematopoietic differentiation.
|
Academic Article
|
High dose cytarabine and mitoxantrone: an effective induction regimen for high-risk acute myeloid leukemia (AML).
|
Academic Article
|
Gene mutations, epigenetic dysregulation, and personalized therapy in myeloid neoplasia: are we there yet?
|
Academic Article
|
Phase I-II study of clofarabine-melphalan-alemtuzumab conditioning for allogeneic hematopoietic cell transplantation.
|
Academic Article
|
The histone code and treatments for acute myeloid leukemia.
|
Academic Article
|
An integrated genomic approach to the assessment and treatment of acute myeloid leukemia.
|
Academic Article
|
Profiles in leukemia.
|
Academic Article
|
Fludarabine, melphalan, and alemtuzumab conditioning in adults with standard-risk advanced acute myeloid leukemia and myelodysplastic syndrome.
|
Academic Article
|
Implications of FLT3 mutations in the therapy of acute myeloid leukemia.
|
Academic Article
|
2-Hydroxyglutarate in IDH mutant acute myeloid leukemia: predicting patient responses, minimal residual disease and correlations with methylcytosine and hydroxymethylcytosine levels.
|
Academic Article
|
Inherited predisposition to acute myeloid leukemia.
|
Academic Article
|
DNA hydroxymethylation profiling reveals that WT1 mutations result in loss of TET2 function in acute myeloid leukemia.
|
Academic Article
|
Inherited and Somatic Defects in DDX41 in Myeloid Neoplasms.
|
Academic Article
|
Familial myelodysplastic syndrome/acute leukemia syndromes: a review and utility for translational investigations.
|
Academic Article
|
On the origin of leukemic species.
|
Academic Article
|
Genomic analysis of germ line and somatic variants in familial myelodysplasia/acute myeloid leukemia.
|
Academic Article
|
Increased DNA methylation of Dnmt3b targets impairs leukemogenesis.
|
Academic Article
|
Novel germ line DDX41 mutations define families with a lower age of MDS/AML onset and lymphoid malignancies.
|
Academic Article
|
Fumarate and Succinate Regulate Expression of Hypoxia-inducible Genes via TET Enzymes.
|
Academic Article
|
Efficacy of single-agent decitabine in relapsed and refractory acute myeloid leukemia.
|
Academic Article
|
Germline ETV6 mutations and predisposition to hematological malignancies.
|
Academic Article
|
Therapy-related myeloid neoplasms: when genetics and environment collide.
|
Academic Article
|
Hereditary Myelodysplastic Syndrome and Acute Myeloid Leukemia: Diagnosis, Questions, and Controversies.
|
Academic Article
|
MBD4: guardian of the epigenetic galaxy.
|
Academic Article
|
Reduced-Intensity Allogeneic Transplant for Acute Myeloid Leukemia and Myelodysplastic Syndrome Using Combined CD34-Selected Haploidentical Graft and a Single Umbilical Cord Unit Compared with Matched Unrelated Donor Stem Cells in Older Adults.
|
Academic Article
|
Identifying patients with genetic predisposition to acute myeloid leukemia.
|
Academic Article
|
A phase I study of selinexor in combination with high-dose cytarabine and mitoxantrone for remission induction in patients with acute myeloid leukemia.
|
Academic Article
|
Correct application of variant classification guidelines in germline RUNX1 mutated disorders to assist clinical diagnosis.
|
Academic Article
|
A phase 1 study of azacitidine with high-dose cytarabine and mitoxantrone in high-risk acute myeloid leukemia.
|
Academic Article
|
RUNX1-mutated families show phenotype heterogeneity and a somatic mutation profile unique to germline predisposed AML.
|
Academic Article
|
Germline mutations in MDS/AML predisposition disorders.
|
Academic Article
|
The RUNX1 database (RUNX1db): establishment of an expert curated RUNX1 registry and genomics database as a public resource for familial platelet disorder with myeloid malignancy.
|
Academic Article
|
Diagnosis and management of AML in adults: 2022 recommendations from an international expert panel on behalf of the ELN.
|
Academic Article
|
Clinical and molecular response of acute myeloid leukemia harboring non-canonical FLT3 N676K driver mutations to contemporary FLT3 inhibitors.
|
Academic Article
|
Germ line DDX41 mutations define a unique subtype of myeloid neoplasms.
|
Academic Article
|
Genomic profiling for clinical decision making in myeloid neoplasms and acute leukemia.
|
Academic Article
|
(R)-2-Hydroxyglutarate Inhibits KDM5 Histone Lysine Demethylases to Drive Transformation in IDH-Mutant Cancers.
|
Academic Article
|
Insights into the Molecular Mechanisms of Genetic Predisposition to Hematopoietic Malignancies: The Importance of Gene-Environment Interactions.
|